Integrated ReportFiscal Year Ended Mar. 31, 2024
Our Company
Our Strategy
- 
		Company Strategy and Progress   
- 
		Investments for Patient Safety and Our Future Growth   
- 
		Elevate Employees Roundtable Discussion   
- 
		ESG Strategy   
- 
		Overview and Direction of Three Focus Areas   
- 
		EVIS X1   
- 
		Intelligent Endoscopy Ecosystem   
- 
		Chinese Market   
- 
		Emerging Markets   
- 
		Innovation   
- 
		Strategic M&A   
- 
		Single-use Endoscope   
- 
		Care Pathway Enhancement   
- 
		Intellectual Property Activities   
- 
		Evolving Our Corporate Culture   
- 
		Activities to Improve Productivity   
- 
		Carbon Neutral Society and Circular Economy   
- 
		Responsible Supply Chain   
Our Setup
Data
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012



